We meet Dr. Genet, creator of GeneMatch™

Dr. Alfred Genet stood at the center of his laboratory in Paris, surrounded by the gentle hum of DNA sequencing machines that cost more than most people's houses. The equipment glowed with soft blue light, and holographic displays projected rotating double helix structures into the air around him, casting shifting shadows across his gaunt features. This was where he felt most comfortable, more at home than in his sterile apartment in the Financial District where he spent most nights sleeping on his couch because he forgot to go to bed.

His research team had gathered for their weekly briefing—six geneticists, three data scientists, and two software engineers, all brilliant minds he'd recruited from top universities and tech companies. They sat in ergonomic chairs arranged in a semi-circle, tablets in hand, waiting for him to begin. Alfred pushed his frameless glasses up the bridge of his nose, a nervous habit he'd never managed to break, and tried to ignore the way his mismatched eyes—one blue, one green—made some people uncomfortable when he looked directly at them.

"Right, yes, well," he began, his words tumbling out faster than he intended. "Thank you all for coming. Today we're going to discuss the latest refinements to the GeneMatch algorithm, specifically the correlation matrices we've identified in the HLA-DQB1 allele sequences."

He gestured at the largest holographic display, and it shifted to show a complex network of genetic markers connected by glowing lines. His fingers danced through the air, manipulating the image with practiced ease. This was the language he spoke fluently, the only communication that never felt **** or awkward.

"As you can see here," Alfred continued, his voice gaining confidence as he fell into the familiar rhythm of scientific explanation, "we've isolated 23,847 specific genetic markers across the human genome that correlate with what we're calling 'coital compatibility indices.' The HLA-DQB1 allele correlation indicates 97.3% accuracy in predicting long-term relationship satisfaction between matched partners."

Dr. Sarah Chen, his lead data scientist, raised her hand. "When you say 'coital compatibility,' are we talking about sexual chemistry specifically, or broader relationship dynamics?"

Alfred felt his face flush. God, why did everything have to come back to sex? He understood the genetic mechanisms perfectly—pheromone receptor variations, neurotransmitter response patterns, hormonal compatibility—but discussing the actual physical act made him deeply uncomfortable.

"Well, um, yes, it's—" He cleared his throat and fidgeted with his tablet, pulling up a new dataset to avoid eye contact. "The markers we've identified influence multiple aspects of interpersonal attraction. Pheromone reception, obviously, which governs initial physical attraction. But also dopamine and oxytocin receptor sensitivity, which affects pair-bonding capacity. Serotonin transporter polymorphisms that influence mood compatibility. And yes, variations in genes governing sexual response and libido alignment."

He was talking too fast now, words running together as he tried to get through the explanation as quickly as possible. His left hand had started that annoying tremor it got when he was nervous, so he shoved it into the pocket of his wrinkled lab coat.

"The romantic implications are, uh, significant," Alfred continued, stumbling over the word 'romantic' like it was in a foreign language. "Partners matched by our algorithm report 89% higher satisfaction rates in their, um, intimate relationships compared to conventionally matched couples. The data is quite clear on this point."

He pulled up a graph showing satisfaction metrics, grateful to have numbers to focus on instead of the concept of actual human intimacy. His own experience with relationships was limited to a handful of awkward dates in graduate school that had gone nowhere, and one particularly painful evening where a woman had straight-up laughed when he'd tried to kiss her goodnight. He'd thrown himself into his research after that, deciding that understanding love scientifically was far preferable to experiencing it personally.

"Dr. Genet," called out Marcus Webb, one of his software engineers, "can you walk us through how the app interface presents this data to users? Most people won't understand allele sequences and polymorphisms."

"Right, yes, of course." Alfred swiped his hand through the holographic display, pulling up a mockup of the GeneMatch app interface on the large screen behind him. "We've simplified the presentation considerably for end users."

The screen showed a sleek, minimalist design with a large percentage score—94% GENETIC COMPATIBILITY—displayed prominently at the top. Below it, user profiles featured photos, basic information, and simplified explanations of genetic synergies.

"The algorithm processes all 23,847 markers but translates them into an easy-to-understand compatibility percentage," Alfred explained, his voice steadying as he discussed the technical implementation. "Users can drill down into detailed reports if they choose, but the core matching experience is designed to be intuitive. We've also implemented privacy controls so users can determine who sees their genetic profile and compatibility scores."

He demonstrated the app's various features, his long fingers moving across the tablet with precision. Here, in the realm of user interfaces and data visualization, he felt competent again. It was only when someone brought up the real-world implications—actual people using this to find actual partners for actual relationships—that his confidence wavered.

"The success rate has been remarkable," he continued, pulling up statistics that made his chest swell with pride. "In our beta testing phase, 73% of highly compatible matches resulted in first dates. Of those, 61% progressed to second dates, and 42% have entered exclusive relationships lasting more than six months. These numbers are unprecedented in the online dating industry."

"But how do we account for the subjective experience of attraction?" asked Dr. Chen. "Surely genetics can't predict everything about human connection."

Alfred felt his shoulders tense. This was the question everyone asked eventually, the one that made him defensive because he knew his answer never quite satisfied people.

"Love isn't magic," he said, perhaps more sharply than he intended. "It's chemistry. Literally. The feeling people describe as 'falling in love' is a cascade of neurochemical responses triggered by genetic compatibility. When two people have complementary immune systems, their bodies recognize it through pheromones. When their neurotransmitter systems are aligned, conversation flows easily and rewards them with dopamine hits. When their attachment style genes are compatible, they bond more readily."

He was gesturing wildly now, his usual reserved demeanor giving way to passionate intensity. "We've quantified what humans have been trying to understand for millennia. The data doesn't lie. Two people with 95% genetic compatibility have a biological foundation for long-term satisfaction that simply cannot be replicated by conventional matching methods based on, on shared interests in hiking and favorite movies."

His team was staring at him, and Alfred suddenly realized he'd been almost shouting. He cleared his throat and pushed his glasses up again, fingers trembling slightly.

"That is to say, um, the scientific evidence supports our methodology. Do you understand?"

He didn't wait for an answer, instead turning back to the holographic displays and pulling up another dataset to analyze. His reflection caught in the darkened window of the lab, and he saw what he always saw—a thin, awkward man with prematurely graying hair and mismatched eyes, brilliant in his field but hopelessly incompetent at the very thing he was trying to engineer for others.

The irony wasn't lost on him. He'd created an app that helped thousands of people find love, and yet he remained profoundly, achingly alone. His genetic compatibility with most women tested in the moderate range, and the few high matches he'd tried to contact had either ignored him or politely declined after one look at his profile picture.

"Are there any other questions?" Alfred asked, blinking rapidly behind his glasses, **** to end this briefing and return to the safety of his data.